French 24-year-old youth died after receiving AstraZeneca Vaccine
French 24-year-old youth died after receiving AstraZeneca Vaccine
French 24-year-old youth died after receiving AstraZeneca Vaccine. French 24-year-old youth dies after being vaccinated with AstraZeneca, prosecutor launches investigation.
March 24. A 24-year-old medical student in Nantes, France, Anthony Rio was found dead at home 10 days after being vaccinated with Oxford/AstraZeneca. At present, the Nantes Prosecutor’s Office has launched a judicial investigation and the health agency The specific circumstances of this death case are also being studied.
According to the French newspaper Le Figaro, citing a report by the French La Vecchio, Anthony Rio’s family and friends lost contact with him and reported the case. Firefighters found that he had died in his solitary residence on the 18th local time.
The police found a document at the scene proving that the sixth-year medical school student had been vaccinated with the Oxford/AstraZeneca vaccine during his internship in the hospital on the 8th of this month. The Nantes Prosecutor’s Office has launched an investigation and conducted an autopsy on the 19th to determine the cause of death. The report was sent to the Prosecutor’s Office on the 22nd.
According to sources close to the investigation, the autopsy report mentioned “internal bleeding caused by thrombus.” Nantes prosecutor Pierre Cernes said in a statement that other analyses are ongoing to clarify the specific cause and circumstances of the death and must continue to wait for expert conclusions.
Anthony Rio’s family believed that the death was related to vaccination, because the young man paid attention to his diet and exercise, had no medical history, and did not have any comorbidities. He was very healthy. Vaccination was the only possible explanation.
A spokesperson for the French National Drug Safety Administration said that at this stage there is no evidence that there is a connection between the young man’s death and vaccination, and the local pharmacovigilance center is conducting an in-depth clinical investigation of the death.
According to a report issued by the French National Drug Safety Administration, since the start of the Oxford/AstraZeneca vaccine, as of March 16, the EU and the United Kingdom have reported a total of 25 cases of adverse reactions such as thrombosis and diffuse intravascular coagulation, of which 9 cases Died. However, after approximately 15 European countries suspended vaccination, the European Medicines Agency concluded in a report submitted on March 18 that vaccination would not increase the risk of blood clots, and many European countries have resumed vaccination.
On the morning of the 23rd, the National Institute of Allergy and Infectious Diseases stated that the Oxford/AstraZeneca Laboratories used outdated data in clinical trials in the United States, which may make it impossible to fully evaluate the effectiveness of the vaccine. The laboratory will provide the latest data to U.S. regulators within 48 hours
(source:internet, reference only)
Disclaimer of medicaltrend.org
